undamentalytics Newsletter
Sign in

Amrize Ltd (AMRZ) stock

Add to watchlist

Add holding +

NYSE: AMRZ NYSE Construction Materials Next results ~January 19, 2027

Amrize Ltd is a US-listed company in the construction materials industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$46

Cash-flow model

Base case. Range ~$32–$65 across our lower- and higher-growth cases (-1.5%–8.5% a year).

Price vs value

No Buy/Hold/Sell rating is issued: limited reported history: available models are shown without a Buy/Hold/Sell rating.

Amrize Ltd valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Funds281 adding, 181 cuttingOf 61 active managers that changed their stake, 29 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Amrize files

Where Amrize stands after its latest 10-Q

Revenue for the twelve months to September 2026 was $12.3bn. Free-cash-flow margin fell to 8.8% from 12.0% a year earlier. It passes 4 of our 6 financial-health checks. Our cash-flow model value is $45.58 a share, against a share price of $41.38.

Source: 10-Q filed October 29, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~January 19, 2027 (estimated)

Amrize Ltd's trailing-twelve-month revenue grew 3.5% year on year, with a free-cash-flow margin of 8.8%.

Our discounted-cash-flow model values the business at ~$46 per share in the base case (~$32–$65 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow fell 24.4% while net income grew 8.3%: a 33pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

Nothing in Amrize Ltd's latest figures clears our strength thresholds.

Things to watch

  • Missing expectations. Earnings per share fell short of the consensus estimate in 3 of the last four quarters.
  • Estimates being cut. Analysts' consensus for next year's earnings per share has fallen 15.3% over 90 days.

Latest results: FY2026 Q3

Filed October 29, 2026
Earnings per share
$1.02 against an average estimate of $1.00: beat by 2.0%
Revenue
$3.77bn, up 2.2% on a year earlier
Share reaction
+3.4% in the first session after the results on October 28, 2026, against 0.0% for the S&P 500
Guidance given
revenues $12.2bn to $12.4bn (FY 2026); adjusted EBITDA $2.95bn to $3.05bn (FY 2026)
Next report
October 28, 2026; average EPS estimate $0.61

Amrize's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+4.7%
  • 1 week+10.4%
  • 1 month+16.2%
  • This year-18.9%
  • 1 year-15.4%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$12.3B
Operating margin
15.5%
Net margin
10.2%
EPS (TTM, diluted)
$2.27

Growth

Revenue growth
+3.5%
Change in growth rate
−1.5 pts

Cash

Free cash flow (TTM)
$1.1B
FCF margin
8.8%
Stock pay % of revenue
0.3%

Earnings

Last results
October 28, 2026
Next results (est.)
January 19, 2027

News & updates

Updated November 1, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Guidance
  3. Leadership
  4. Leadership
  5. Leadership
  6. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Amrize Ltd valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: limited reported history: available models are shown without a Buy/Hold/Sell rating.

Our value per share comes from a discounted-cash-flow model of Amrize Ltd's free cash flow after stock-based pay ( $1.7B, FY2026 Q3 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation models

We value Amrize Ltd as an operating company, with every model that fits that kind of business. Cost of equity 9.7%: the 10-year Treasury yield (4.9%) plus a beta of 1.05 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$46 ~$32–$65 Primary model, counts double
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$48 ~$40–$70 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$25 ~$17–$38 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$25 ~$22–$29 Included
Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$38 ~$25–$48 4 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Amrize Ltd with Construction Materials in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

What moves the value

  • Revenue growth 5 points lower ▼ −33%
  • Revenue growth 5 points higher ▲ +43%
  • Free-cash-flow margin 1 point lower ▼ −12%
  • Last year's free-cash-flow margin change, if it persists ▼ −28%
  • Discount rate 1 point higher ▼ −19%
Value per share under different assumptions
Discount rate ↓ / growth → −5% growth0% growth5% growth10% growth15% growth20% growth
7% $34$50$71$99$135$182
8.5% $23$35$50$70$96$129
10% $17$26$38$53$73$98

Valuation multiples over time Market data may be delayed

At fiscal year end 2025Now
Share price$53.42$43.31
Market value$29.6bn$23.9bn
+ Net debt (− = net cash)$3.3bn$5.5bn
Enterprise value$32.9bn$29.4bn
Multiples
Price / sales 2.5x1.9x
Price / earnings 25.0x19.1x
Price / free cash flow 20.8x22.2x
EV / EBITDA 12.4x10.8x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $2.31 +8% $12.5bn +6%
Next $2.63 +14% $13.1bn +5%

Next year's EPS estimate has moved −15.3% in 90 days, across 16 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −13.8% on 90 days ago. In the last 30 days, 3 analysts raised Amrize Ltd's forecast and 11 cut it.

Consensus EPS forecast Amrize Ltd, last 90 days
$2.20 $2.40 $2.60 $2.80 $3.00 $3.20 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $2.68 Current fiscal year, 60 days ago: $2.48 Current fiscal year, 30 days ago: $2.46 Current fiscal year, 7 days ago: $2.42 Current fiscal year, Now: $2.31 $2.31 Next fiscal year, 90 days ago: $3.10 Next fiscal year, 60 days ago: $2.92 Next fiscal year, 30 days ago: $2.78 Next fiscal year, 7 days ago: $2.70 Next fiscal year, Now: $2.63 $2.63

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $2.68$3.10
60 days ago $2.48$2.92
30 days ago $2.46$2.78
7 days ago $2.42$2.70
Now $2.31$2.63

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 $1.00 $1.02 +2.0%
Jun 2026 $0.94 $0.86 −8.8%
Mar 2026 −$0.15 −$0.21 −39.8%
Dec 2025 $0.64 $0.54 −16.2%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, October 28, 2026
  • Revenues FY 2026 $12.2bn to $12.4bn
    “Revenues $12.2 billion to $12.4 billion” source
  • Adjusted EBITDA FY 2026 $2.95bn to $3.05bn Non-GAAP
    “Adjusted EBITDA $2.95 billion to $3.05 billion” source
  • Capital Expenditures 2026 about $900m
    “Capital Expenditures ~$900 million” source
  • Interest Expense, Net 2026 about $340m
    “Interest Expense, Net ~$340 million” source
  • Adjusted Effective Tax Rate 2026 23% to 25% Non-GAAP
    “Adjusted Effective Tax Rate 23% - 25%” source
  • Corporate Costs 2026 about $200m
    “Corporate Costs ~$200 million” source
Show 1 more item
  • ASPIRE program savings 2026 about $80m
    “The program is on track to achieve $80 million of savings in 2026.” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

How our valuation uses these forecasts

Our cash-flow model grows Amrize Ltd's revenue by +4.4% next year and +3.9% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+5.3%, weight 46%) , management guidance (+3.8%, weight 32%) and the company's own record (+3.5%, weight 22%) . How the weights are set.

Analyst recommendations

20 analysts, Oct 2026
Buy945%
Hold945%
Sell210%

Monthly trend

  1. Oct 2026279220
  2. Sep 20262710221
  3. Aug 202648821
  4. Jul 202648820

Counts of recommendations published by analysts covering Amrize Ltd, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
2.4%
of tradable shares
Days to cover
3.47
at average volume
Short interest, 1 month
+29%
to October 15, 2026
Held by institutions
53%
of shares
Held by insiders
7.6%
of shares
Employees
190,000
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −15.4%

$51.21 on October 31, 2025 to $43.31

ThenNowEffect
Revenue (last 12 months) $11.6bn $12.2bn +5.0%
Net margin 10.1% 10.1% +0.8%
P/E multiple 24.3x 19.4x −20.0%
Share count 553m 554m −0.1%

Biggest factor: p/e multiple.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 2026 to date
Return
AMRZ−19%
Industry peers (median)−5%
S&P 500+11%
Months that ended higher
AMRZ36%
S&P 50046%
Largest fall from a high during the year
AMRZ−45%
S&P 500−9%

Worst fall since June 23, 2025: 45% from February 24, 2026 to October 12, 2026. Getting back needed a 80% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$36.09 – $65.06
From 52-week high
−33.4%
vs 50-day average
+9.2%
vs 200-day average
−13.7%
Volatility (1 year)
37%
Beta vs S&P 500
1.25

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
3 up, 3 down
typical move ±7.2%
After a week
3 up, 2 down
typical move ±6.6%
After a month
2 up, 3 down
typical move ±7.3%
Results releasedNext dayS&P 500 next day5 days21 days
October 28, 2026 +3.4% 0.0% — —
August 6, 2026 −11.8% +0.5% −11.6% −16.9%
April 29, 2026 −6.4% +1.0% −4.4% −5.2%
February 17, 2026 +8.3% +0.7% +11.9% −7.1%
October 28, 2025 +6.0% +0.3% +2.2% +0.6%
August 6, 2025 −7.1% +0.7% +2.7% +6.9%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Revenue (TTM) Amrize Ltd
$11.6B $11.8B $12B $12.2B $12.4B FY25 Q1 FY25 Q3 FY26 Q1 FY26 Q3 Revenue (TTM), FY25 Q1: $11.6B Revenue (TTM), FY25 Q2: $11.6B Revenue (TTM), FY25 Q3: $11.8B Revenue (TTM), FY25 Q4: $11.8B Revenue (TTM), FY26 Q1: $11.9B Revenue (TTM), FY26 Q2: $12.2B Revenue (TTM), FY26 Q3: $12.3B $12.3B

Source: SEC EDGAR filings. Retrieved October 31, 2026.

View chart data
Period Revenue (TTM)
FY25 Q1 $11.6B
FY25 Q2 $11.6B
FY25 Q3 $11.8B
FY25 Q4 $11.8B
FY26 Q1 $11.9B
FY26 Q2 $12.2B
FY26 Q3 $12.3B
Operating margin (TTM) Amrize Ltd
15% 16% 17% 18% 19% FY25 Q1 FY25 Q3 FY26 Q1 FY26 Q3 Operating margin (TTM), FY25 Q1: 18.3% Operating margin (TTM), FY25 Q2: 17.5% Operating margin (TTM), FY25 Q3: 16.6% Operating margin (TTM), FY25 Q4: 16.1% Operating margin (TTM), FY26 Q1: 15.4% Operating margin (TTM), FY26 Q2: 15.5% Operating margin (TTM), FY26 Q3: 15.5% 15.5%

Source: SEC EDGAR filings. Retrieved October 31, 2026.

View chart data
Period Operating margin (TTM)
FY25 Q1 18.3%
FY25 Q2 17.5%
FY25 Q3 16.6%
FY25 Q4 16.1%
FY26 Q1 15.4%
FY26 Q2 15.5%
FY26 Q3 15.5%
FCF margin (TTM) Amrize Ltd
8% 9% 10% 11% 12% 13% FY25 Q2 FY25 Q3 FY25 Q4 FY26 Q1 FY26 Q2 FY26 Q3 FCF margin (TTM), FY25 Q2: 10.0% FCF margin (TTM), FY25 Q3: 12.0% FCF margin (TTM), FY25 Q4: 12.0% FCF margin (TTM), FY26 Q1: 11.0% FCF margin (TTM), FY26 Q2: 10.8% FCF margin (TTM), FY26 Q3: 8.8% 8.8%

Source: SEC EDGAR filings. Retrieved October 31, 2026.

View chart data
Period FCF margin (TTM)
FY25 Q2 10.0%
FY25 Q3 12.0%
FY25 Q4 12.0%
FY26 Q1 11.0%
FY26 Q2 10.8%
FY26 Q3 8.8%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2025, from the 10-K

Each dollar Amrize took in during FY2025, followed through to profit: what it cost to make, what went on running the business, and what was left after tax.

  1. Revenue $11.8B
  2. Cost of revenue $8.8B · 74.3%
  3. Gross profit $3B · 25.7%
  4. Selling, general and admin $1.1B · 9.5%
  5. Operating income $1.9B · 16.1%
  6. Income tax $326M · 2.8%
  7. Interest and other $395M · 3.3%
  8. Net income $1.2B · 10.0%

Shares of revenue. Source: Amrize's 10-K for FY2025, as filed with the SEC. "Other" lines are what the reported lines leave unexplained.

Financial statements

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Sept 2026
Income
Revenue 11.7 11.7 11.8 12.3
Gross profit 2.8 3.1 3.0 3.0
EBITDA 2.6 2.9 2.7 2.7
Operating income 1.9 2.2 1.9 1.9
Net income 1.0 1.3 1.2 1.3
Diluted EPS $1.73 $2.30 $2.14 $2.27
Growth (year on year)
Revenue — +0.2% +0.9% +3.5%
EBITDA — +13.7% −9.1% −0.1%
Operating income — +16.3% −13.2% −3.5%
Net income — +33.3% −7.0% +8.3%
Diluted EPS — +32.9% −7.0% —
Margins
Gross margin 23.7% 26.2% 25.7% 24.8%
EBITDA margin 22.1% 25.0% 22.5% 22.3%
Operating margin 16.2% 18.8% 16.1% 15.5%
Net margin 8.2% 10.9% 10.0% 10.2%
Free-cash-flow margin 12.0% 14.0% 12.0% 8.8%
Cash flow
Cash from operations 2.0 2.3 2.2 2.0
Capital spending 0.6 0.6 0.8 0.9
Free cash flow 1.4 1.6 1.4 1.1
Stock-based pay 0.0 0.0 0.0 0.0
Free cash flow after stock pay 1.4 1.6 1.4 1.0
Balance sheet
Cash 1.1 1.6 1.9 0.3
Total debt 0.0 0.0 5.3 5.8
Net debt (negative = net cash) −1.1 −1.6 3.3 5.5
Diluted shares 553m 553m 554m 552m

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

4 of 6 checks passed · September 30, 2026
What it owns · $24.4bn
Short-term assets $4.2bnLonger-term assets $20.1bn
What it owes, and who funded it · $24.4bn
Short-term liabilities $4.0bnLonger-term liabilities $7.6bnShareholders' equity $12.8bn
  • Short-term assets cover short-term liabilities $4.2bn of assets due within a year against $4.0bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities $4.2bn short-term assets against $7.6bn of longer-dated liabilities.
  • More cash than debt $299m of cash against $4.9bn of debt.
  • Debt below 40% of shareholders' equity Debt is 39% of equity.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt $2.0bn of operating cash flow against $4.9bn of debt.
  • Operating profit covers interest at least five times over Operating income of $1.9bn against $357m of interest.

From Amrize Ltd's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Sales & admin spending
9.3%
of revenue

Competitors: side by side with peers

Closest by revenue in construction materials
Last 12 months unless stated AMRZ VMC MLM CRH KNF EXP Median
Revenue, last 12 months $12.3bn $8.0bn $6.7bn $39.0bn $3.3bn $2.3bn $3.3bn
Revenue growth, last 12 months 3.5% 1.6% 14.8% 5.6% 12.1% 1.7% 4.5%
Revenue growth, 3-year average — 1.4% 1.1% — 8.3% 2.0% 5.2%
Revenue growth, latest quarter 2.2% −4.7% 21.0% 3.0% 12.6% 2.6% 3.5%
Gross margin 24.8% 27.5% 28.2% 36.2% 17.8% 27.0% 27.0%
Operating margin 15.5% 20.3% 20.6% 13.7% 8.3% 31.7% 16.1%
Operating margin, 3-year average — 19.7% 30.3% 13.5% 9.3% 31.6% 19.7%
Net margin 10.2% 13.8% 36.7% 9.2% 4.2% 17.3% 11.1%
Cash from operations / revenue 16.4% 18.9% 22.7% 13.3% 9.5% 27.2% 17.8%
Free-cash-flow margin 8.8% 9.8% 12.1% 6.5% 1.3% 7.3% 8.8%
Free-cash-flow margin, 3-year average — 11.3% 12.6% 6.8% 1.6% 13.5% 11.3%
Stock pay / revenue 0.3% 0.6% 0.7% 0.4% 0.3% 0.9% 0.7%
Change in share count — −1.7% −1.1% −1.4% 0.1% −4.8% −0.5%

Median of all 9 companies we cover in construction materials. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Building Materials $8.5B 72.1% ▲ 2.2%
Building Envelope $3.3B 27.9% ▼ 2.2%
Geography
Region Revenue YoY
United States $9.1B ▲ 0.9%
Central Region $3.6B ▼ 4.8%
Southern Region $3.5B ▲ 11.5%
Canada $2.7B ▼ 0.1%
Great Lakes Region $2.4B ▼ 7.9%
Northeastern Region $1.9B ▼ 3.1%
Pacific Region $1.3B ▲ 5.9%
Other Geographical Regions $29M —

These categories overlap or exclude eliminations, so shares aren't shown.

From Amrize Ltd's 10-K filed February 18, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$13.7B
Institutions reporting
460
Shares held vs prior quarter
▲ 7.5%
Positions opened / closed
65 / 53

Top buyers and sellers, Q2 2026: 281 institutions bought and 181 sold ; the biggest buyer was Invesco Ltd (+8.0M shares) and the biggest seller DZ Bank AG Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main (−4.5M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Vanguard Capital Management LLC $1.1B 21.3M 8.3% ▲ 3.4%
Blackrock, Inc. $862M 16.2M 6.3% ▲ 4.7%
Harris Associates L P $746M 14.0M 5.4% ▲ 23.3%
Norges Bank $746M 14.1M 5.4% —
Zurcher Kantonalbank (Zurich Cantonalbank) $576M 10.8M 4.2% ▲ 1.6%
Invesco Ltd. $458M 8.6M 3.3% ▲ 1259.1%
UBS Group AG $440M 8.3M 3.2% ▼ 24.4%
DZ Bank AG Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main $402M 7.5M 2.9% ▼ 37.2%
Vanguard Fiduciary Trust Co $389M 7.3M 2.8% ▲ 3.2%
Geode Capital Management, LLC $329M 6.2M 2.4% ▼ 1.1%
Pictet Asset Management Holding SA $312M 5.9M 2.3% ▲ 12.6%
State Street Corp $281M 5.3M 2.1% ▲ 14.3%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Amrize Ltd's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $0 net buying

No open-market insider trades reported in the last 12 months.

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around January 19, 2027 estimated from the company's past filing pattern, not announced

  • October 28, 2026
  • August 6, 2026
  • April 29, 2026
  • February 17, 2026
  • October 28, 2025
  • August 6, 2025

Recent SEC filings

Data status

When each part of this page on Amrize Ltd was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Amrize Ltd in brief

What does Amrize Ltd do?
Amrize Ltd is a US-listed company in the construction materials industry. Its financial year ends in December.
What is Amrize Ltd's stock ticker?
Amrize Ltd trades under the ticker AMRZ on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Amrize Ltd's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Amrize Ltd reported revenue of $12.3B, 3.5% higher than a year earlier, according to its SEC filings.
What is Amrize Ltd's free cash flow?
Amrize Ltd's free-cash-flow margin is 8.8% of revenue over the trailing twelve months.
What is Amrize Ltd's model value per share?
Our discounted-cash-flow model of Amrize Ltd's free cash flow after stock-based pay gives ~$46 per share in the base case, and ~$32–$65 across growth scenarios. These are model values under stated assumptions — not a price target or a recommendation. No Buy/Hold/Sell rating is issued: limited reported history: available models are shown without a Buy/Hold/Sell rating.
Who are Amrize Ltd's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Vanguard Capital Management LLC, Blackrock, Inc. and Harris Associates L P. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Amrize Ltd's market cap?
On November 2, 2026, Amrize Ltd's market capitalisation was about $23.9B, with a price-to-earnings ratio of 19.1 and net debt of $5.5B. Market figures come from third-party market data and may be delayed.
How much debt does Amrize Ltd have?
Amrize Ltd's debt-to-equity ratio is 38.7%, from its latest balance sheet. The financial health section below sets out its other solvency checks.
Who are Amrize Ltd's competitors?
In our Construction Materials peer group, the companies closest to Amrize Ltd are Vulcan Materials Company, Martin Marietta Materials, CRH plc, Knife River Corp and Eagle Materials Inc. The side-by-side comparison below sets their revenue, margins and growth against Amrize Ltd's.
When is Amrize Ltd's next earnings date?
Around January 19, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Amrize Ltd announces its own schedule.